Search

everythinglearnresearchcommunity

for

Search:↓

People with HIV and low T cell counts have more hair and scalp problems.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Potassium levels affect blood sugar and insulin during dialysis, and malnutrition changes children's hair roots.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Dermatologists can help detect and manage eating disorders by recognizing skin changes.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Saw palmetto extract reduced hair loss and improved hair growth in people with hair thinning.

Thyroid problems can cause hair loss and change hair texture.

Nutritional supplements can significantly reduce hair loss in telogen effluvium after three months.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Some people with chronic hair loss may have thyroid autoimmunity.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Covid-19 can cause hair loss due to immune and psychological factors.

Visualizing data helps guide future androgenetic alopecia research and policies.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Data visualization tools are crucial for understanding and advancing androgenetic alopecia research.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.

Hair tourniquet syndrome can cause serious harm if not treated quickly, especially in infants.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.